Inhibition of extracellular matrix-degrading endopeptidases: Problems, comments, and hypotheses

Biological Chemistry

Volumn 379, Issue 8-9, 1998, Pages 1007-1018

  Baici, Antonio ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Bioavailability; Cathepsin B; Kinetics; Osteoarthritis; Pharmacology; Toxicity

Indexed keywords

ENZYME INHIBITOR; PROTEINASE;

CHEMISTRY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HYPOTHESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ENDOPEPTIDASES; EXTRACELLULAR MATRIX; HUMANS; HYDROLYSIS; KINETICS; SUBSTRATE SPECIFICITY;

EID: 0031690566     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. LAlgner, T., Bertling, W., Stoss, H., Weseloh, G., and von der Mark, K. (1993). Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J. Clin. Invest. 91, 829-837.
2. Aignr, T., Vornehm, S.I., Zeiler, G., Dudhia, J., von der Mark, K., and Bayliss, M.T. (1997). Suppression of cartilage matrix gene expression In upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum. 40, 562-569.
3. Alpegiani, M., Baici, A., Bissolino, P., Carminati, P., Cassinelll, G., Del Nero, S., Franceschi, G., Orezzi, P., Perrone, E., Rizzo, V., and Sacchi, N: (1992). Synthesis and evaluation of new elastase inhibitors. 1.1,1-Dioxocephem-4-thiolesters. Eur. J. Med. Chem. 27, 875-890.
4. Alpegiani, M., Bissolino, P., Corigli, R., Del Nero, S., Perrone, E., Rizzo, V., and Baici, A. (1994). Cephem sulfones as inactivators of human leukocyte elastase, 5. 7α-methoxy- and 7α-chloro1,1-dioxocephem 4-ketones. J. Med. Chem. 37, 4003-4019.
5. Amin, A.R., Di Cesare, P.E., Vyas, P., Attur, M., Tzeng, E., Billiar, T.R., Stuchin, S.A., and Abramson, S.B. (1995). The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase, J. Exp. Med. 182, 2097-2102.
6. Arner, E.C., and Tortorella, M.D. (1995). Signal transduction through chondrocyte integrin receptors induces matrix metalloproteinase synthesis and synergizes with interleukin-1. Arthritis Rheum. 38, 1304-1314.
7. Baggiolini, M., and Dewald, B. (1984). Exocytosis by neutrophils. In: Regulation of Leukocyte Function, R. Snyderman, ed. (New York: Plenum Press), pp. 221-246.
8. Baici, A. (1988). Criteria for the choice of inhibitors of extracellular matrix-degrading endopeptidases. In: The Control of Tissue Damage, A.M. Glauert, ed. (Amsterdam: Elsevier), pp. 243-258.
9. Baici, A. (1990). Interaction of human leukocyte elastase with soluble and insoluble protein substrates. A practical kinetic approach. Biochim. Biophys. Acta 1040, 355-364.
10. Baici, A. (1992). Kinetics of the interaction of human leucocyte elastase with protein substrates: Implications for enzyme inhibition. In: Biochemistry of Pulmonary Emphysema, C. Grassi, J. Travis, L. Casali and M. Luisetti, eds. (Berlin/Verona: Springer/Bi&Gi Publishers), pp. 81-100.
11. Baici, A., and Knöpfel, M. (1986). Cysteine proteinases produced by cultured rabbit V2 carcinoma cells and rabbit skin fibroblasts. Int. J. Cancer 38, 753-761.
12. Baici, A., and Lang, A. (1990s). Cathepsin B secretion by rabbit articular chondrocytes: modulation by cycloheximide and glycosaminoglycans. Cell Tissue Res. 259, 567-573.
13. Baici, A., and Lang, A. (1990b). Effect of interleukin-1β on the production of cathepsin B by rabbit articular chondrocytes. FEBS Lett. 277, 93-96.
14. Baici, A., and Seemüller, U. (1984). Kinetics of the inhibition of human leucocyte elastase by eglin from the leech Hirudo medicinalis. Biochem. J. 218, 829-833.
15. Baici, A., and Sträuli, P. (1985). Release of proteinases by cultures of human cell lines derived from squamous carcinomas of the tongue and larynx. Exp. Cell Biol. 53, 213-219.
16. Baici, A., Gyger-Marazzi, M., and Sträuli, P. (1984). Extracellular cysteine proteinase and collagenase activities as a consequence of tumor-host interactions in the rabbit V2 carcinoma. Invas. Metast. 4, 13-27.
17. Baici, A., Knöpfel, M., and Keist, R. (1988a). Tumor-host interactions in the rabbit V2 carcinoma: Stimulation of cathepsin B in host fibroblasts by a tumor-derived cytokine. Invas. Metast. 8, 143-158.
18. Baici, A., Lang, A., Hörler, D., and Knopfel, M. (1988b). Cathepsin B as a marker of the dedifferentiated chondrocyte phenotype. Ann. Rheum. Dis. 47, 684-691.
19. Baici, A., Pelloso, R., and Hörler, D. (1990). The kinetic mechanism of inhibition of human leukocyte elastase by MR889, a new cyclic thiolic compound. Biochem. Pharmacol. 39, 919-924.
20. Baici, A., Hörler, D., Lang, A., Merlin, C., and Kissling, R. (1995a). Cathepsin B in osteoarthritis: zonal variation of enzyme activity in human femoral head cartilage. Ann. Rheum, Dis. 54, 281-288.
21. Baici, A., Lang, A., Hörler, D., Kissling, R., and Merlin, C. (1995b). Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage. Ann. Rheum. Dis. 54, 289-297.
22. Bandara, G., Lin, C.W., Georgescu, H.I., Mendelow, D., and Evans, C.H. (1989a). Chondrocyte activation by interleukin-1: analysis of the synergistic properties of fibroblast growth factor and phorbol myristate acetate. Arch. Biochem. Biophys. 274, 539-547.
23. Bandara, G., Lin, C.W., Georgescu, H.I., Mendelow, D., and Evans, C.H. (1989b). Chohdrocyte activation by interleukin-1: Synergism with fibroblast growth factor and phorbol myristate acetate. Agents Actions 27, 439-441.
24. Barrett, A.J., ed. (1977). Proteinases in Mammalian Cells and Tissues, Research Monographs in Cell and Tissue Physiology, Volume 2, J.T. Dingle, ed. (Amsterdam: North-Holland).
25. Beckett, R.P., Davidson, A.H., Drummond, A.H., Huxley, P., and Whittaker, M. (1996). Recent advances in matrix metalloproteinase inhibitor research. Drug Discov. Today 1, 16-26.
26. Bieth, J.G. (1980). Pathophysiological interpretation of kinetic constants of protease inhibitors. Bull. Eur. Physiopathol. Respir. 16 Suppl., 183-195.
27. Bieth, J.G. (1984). In vivo significance of kinetic constants of protein proteinase inhibitors. Biochem. Med. 32, 387-397.
28. Büttner, F.H., Chubinskaya, S., Margerie, D., Much, K., Flechtenmacher, J., Cole, A.A., Kuettner, K.E., and Bartnik, E. (1997). Expression of membrane type 1 matrix metalloproteinase in human articular cartilage. Arthritis Rheum. 40, 704-709.
29. Carney, S.L., and Muir, H. (1988). The structure and function of cartilage proteoglycans. Physlol. Rev. 68, 858-910.
30. Chambers, A.F., and Matrisian, L.M. (1997). Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 1260-1270.
31. Cole, A.A., Chubinskaya, S., Schumacher, B., Huch, K., Cs-Szabó, G., Yao, J., Mikecz, K., Hasty, K.A., and Kuettner, K.E. (1996). Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J. Biol. Chem. 271, 11023-11026.
32. Corcoran, M.L, Hewitt, R.E., Kleiner, D.E., Jr., and Stetler-Stevenson, W.G. (1996). MMP-2: Expression, activation and inhibition. Enzyme Protein 49, 7-19.
33. Csernok, E., Ernst, M., Schmitt, W., Bainton, D.F., and Gross, W.L. (1994). Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin. Exp. Immunpl. 95, 244-250.
34. Cushman, D.W., and Ondetti, M.A. (1991). History of the design of captopril and related inhibitors of angiotensin converting enzyme. Hypertension 17, 589-592.
35. Davies, M., Barrett, A.J., Travis, J., Sanders, E., and Coles, G.A. (1978). The degradation of human glomerular basement membrane with purified lysosomal proteinases: evidence for the pathogenic role of the polymorphonuclear leucocyte in glomerulonephritis. Clin. Sci. Mol. Med. 54, 233-240.
36. Deshmukh-Phadke, K., Lawrence, M., and Nanda, S. (1978). Synthesis of collagenase and neutral protease by articular chondrocytes. Stimulation by a macrophage derived factor Biochem. Biophys. Res. Commun. 85, 490-496.
37. Dewald, B., Bretz, U., and Baggiolini, M. (1982). Release of gelatinase from a novel secretory compartment of human neutrophils. J. Clin. Invest. 70, 518-525.
38. Dieppe, P. (1990). Osteoarthritis. A review. J. Roy. Coll. Physicians London 24, 262-267.
39. Edwards, P.D., and Bernstein, P.R. (1994). Synthetic inhibitors of elastase. Med. Res. Rev. 14, 127-194.
40. Eriksson, S. (1991). The potential role of elastase inhibitors in emphysema treatment. Eur. Respir. J. 4, 1041-1043.
41. Evans, C.H., Mears, D.C., and Cosgrove, J.L (1981). Release of neutral proteinases from mononuclear phagocytes and synovial cells in response to cartilaginous wear particles in vitro-Biochim. Biophys. Acta 677, 287-294.
42. Fell, H.B., Barratt, M.E.J., Welland, H., Green, R., and Poole, A.R. (1976). The capacity of pig articular cartilage in organ culture to regenerate after breakdown induced by complement-sufficient antiserum to pig erythrocytes. Calcif. Tissue Res. 20, 3-21.
43. Frieden, C. (1970). Kinetic aspects of regulation of metabolic processes. The hysteretic enzyme concept. J. Biol. Chem. 245, 5788-5799.
44. Goldring, M.B., Birkhead, J., Sandell, L.J., Kimura, T., and Krane, S.M. (1988). Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagonsjn human chondrocytes. J. Clin. Invest. 82, 2026-2037.
45. Graf, M., Baici, A., and Sträuli, P. (1981). Histochemical localization of cathepsin B at the invasion front of the rabbit V2 carcinoma. Lab. Invest. 45, 587-596.
46. Groutas, W.C. (1987). Inhibitors of leukocyte elastase and leukocyte Cathepsin G. Agents for the treatment of emphysema and related ailments. Med. Res. Rev. 7, 227-241.
47. Henson, P.M. (1971a). The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and comptement on nonphagocytosable surfaces or phagocytosable particles. J. Immunol. 107, 1535-1546.
48. Henson, P.M. (1971b). The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis and adherence to nonphagocytosable surfaces. J. Immunol. 107, 1547-1557.
49. Henson, P.M. (1971 c). Interaction of cells with immune complexes: Adherence, release of constituents, and tissue injury. J. Exp. Med. 134, 114s-135s.
50. Holmdahl, R., Malmstrom, V., and Vuorio, E. (1993). Autoimmune recognition of cartilage collagens. Ann. Med. 25, 251-264.
51. Holtzer, H., Abbott, J., Lash, J., and Holtzer, S. (1960). The loss of phenotypic traits by differentiated cells in vitro, I. Dedifferentiation of cartilage cells. Proc. Natl. Acad. Sci. USA 46, 1533-1542.
52. Huisman, W., Lanting, L., Doddema, H.J., Bouma, J.M.W., and Gruber, M. (1974). Role of individual cathepsins in lysosomal protein digestion as tested by specific inhibitors. Biochim. Biophys. Acta 370, 297-307.
53. Hulboy, D.L., Rudolph, L.A., and Matrisian, L.M. (1997). Matrix metalloproteinases as mediators of reproductive function. Mol. Hum. Reprod. 3, 27-45.
54. Ip, M.P.C., Kleinerman, J., Ranga, V., Sorensen, J., and Powers, J.C. (1981). The effects of small doses of oligopeptide elastase inhibitors on elastase-induced emphysema in hamsters: a dose-response study. Amer. Rev. Respir. Dis. 124, 714-717.
55. Janoff, A., and Dearing, R. (1980). Prevention of elastase-induced experimental emphysema by oral administration of a synthetic elastase inhibitor. Amer. Rev. Respir. Dis. 121, 1025-1030.
56. Johnson, R.J., Couser, W.G., Alpers, C.E., Vissers, M., Schulze, M., and Klebanoff, S.J. (1988). The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo. J. Exp. Med. 168, 1169-1174.
57. Keppler, D., Sameni, M., Moin, K., Mikkelsen, T., Diglio, C.A., and Sloane, B.F. (1996). Tumor progression and angiogenesis: Cathepsin B & Co. Biochem. Cell Biol. 74, 799-810.
58. Kettner, C.A., and Shenvi, A.B. (1984). Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids. J. Biol. Chem. 259, 15106-15114.
59. Klein, J.B. (1993). Immunologic renal injury. Curr. Opin. Nephrol. Hypert. 2, 225-230.
60. Köppel, P., Baici, A., Keist, R., Matzku, S., and Keller, R. (1984). Cathepsin B-like proteinase as a marker for metastatic tumor cell variants. Exp. Cell Biol. 52, 293-299.
61. Kostoulas, G., Lang, A., Trueb, B., and Baici, A. (1997). Dffferential expression of mRNAs for endopeptidases in phenotypically modulated ('dedifferentiated') human articular chondrocytes. FEBS Lett. 412, 453-455.
62. Lehrer, R.I., and Ganz, T. (1990). Antimicrobial polypeptides of human neutrophils. Blood 76, 2169-2181.
63. Liotta, L.A. (1992). Cancer celt invasion and metastasis. Sci. Amer. 266, 34-41.
64. Mankin, H.J. (1973). Biochemical and metabolic abnormalities in osteoarthritic human cartilage. Fed. Proc. 32, 1478-1480.
65. Mankin, H.J., and Lippiello, L. (1971). The glycosaminoglycans of normal and arthritic cartilage. J. Clin. Invest. 50, 1712-1719.
66. Mankin, H.J., Dorfman, H., Lippiello, L., and Zarins, A. (1971). Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J. Bone Joint Surg.Amer. Vol. 53-A, 523-537.
67. Matrisian, L.M. (1990). Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6, 121-125.
68. Matsunaga, Y., Saibara, T., Kido, H., and Katunuma, N. (1993). Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS Lett. 324, 325-330.
69. McGuire-Goldring, M.B., Meats, J.E., Wood, D.D., Ihrie, E.J., Ebsworth, N.M., and Russell, R.G.G. (1984). In vitro activation of human chondrocytes and synoviocytes by a human interleukin-1 -lkefactor. Arthritis Rheum. 27, 654-662.
70. Meats, J.E., McGuire, M.B., and Russell, R.G.G. (1980). Human synovium releases a factor which stimulates chondrocyte production of PGE and plasminogen activator. Nature 286, 891-892.
71. Mitchell, P.G., Magna, H.A., Reeves, L.M., Lopresti-Morrow, L.L., Yocum, S.A., Rosner, P.J., Geoghegan, K.F., and Hambor, J.E. (1996). Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97, 761-768.
72. Morrison, J.F., and Stone, S.R. (1985). Approaches to the study and analysis of the inhibition of enzymes by slow- and tight-binding inhibitors. Comments Mol. Cell. Biophys. 2, 347-368.
73. Mort, J.S., Recklies, A.D., and Poole, A.R. (1980). Characterization of a thiol proteinase secreted by malignant human breast tumors. Biochim. Biophys. Acta 614, 134-143.
74. Nagase, H. (1997). Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378, 151 -10.
75. Nimni, M.E., and Deshmukh, K. (1973). Differences in collagen metabolism between normal and osteoarthritic human articularcartiiage. Science 181, 751-752.
76. Ohta, S., Imai, K., Yamashita, K., Matsumoto, T., Azumano, I., and Okada, Y. (1998). Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage. Lab. Invest. 78, 79-87.
77. Opie, L.H., and Kowolik, H. (1995). The discovery of captopril: from large animals to small molecules. Cardiovasc. Res. 30, 18-25.
78. Owen, C.A., Campbell, M.A., Sannes, P.L., Boukedes, S.S., and Campbell, E.J. (1995). Cell surface-bound elastase and cathepsin G on human neutrophils: A novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 131, 775-789.
79. Palmer, R.M.J., Hickory, M.S., Charles, I.G., Moncada, S., and Bayliss, M.T.(1993). Induction of nitric oxide synthase in human chondrocytes. Biochem. Biophys. Res. Commun. 193, 398-405.
80. Pel, D., and Weiss, S.J. (1995). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375, 244-247.
81. Pelletier, J.P., DiBattista, J.A., Roughley, P., McCollum, R., and Martel-Pelletier, J. (1993). Cytokines and inflammation in cartilage degradation. Rheum. Dis. Clin. N. Amer. 19, 545-568.
82. ESNOPOSPoole, A.R., Alini, M., and Hollander, A.P. (1995). Cellular biology of cartilage degradation. In: Mechanisms-and: Models in Rheumatoid Arthritis, B.Henderspn, J.C.W. Edwards and E.R. Pettipher, eds. (London: Academic Press), pp. 163-204.
83. Qian, F., Chan, S.J., Achkar, C., Steiner, D.F., and Frankfater, A. (1994). Transcriptional regulation of cathepsin B expression in B16 melanomas of varying metastatic potential. Biochem. Biophys. Res. Commun. 202, 429-436.
84. Ray, J.M., and Stetler-Stevenson, W.G. (1994). The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Respir, J. 7, 2062-2072.
85. Robert, B., Hornebeck, W., and Robert, L. (1974). Cinétique hétérogéne de l'interaction élastine-élastase. Biochimie 56, 239-244.
86. Sakamoto, S., and Sakamoto, M. (1982). Biochemical and immunohistochemical studies on collagenase in resorbing bone in tissue culture. A novel hypothesis for the mechanism of bone resorption. J. Period. Res. 17, 523-526.
87. Sakamoto, S., and Sakamoto, M. (1988). Degradative processes of connective tissue proteins with special emphasis on collagenolysis and bone resorption. Mol. Aspects Med, 10, 299-428.
88. Sandler, M., and Smith, H.J., eds. (1989). Design of Enzyme Inhibitors as Drugs (Oxford: Oxford University Press).
89. Schnebli, H.R, Seemüller, U., Fritz, H., Maschler, R., Liersch, M., Virca, G.D., Bodmer, J.L., Snider, G.L., Lucey, E.G., and Stone, P.G. (1985). Eglin c, a pharmacologically active elastase inhibitor. Eur. J. Respir. Dis. 66 Suppl. 139, 66-70.
90. Sloane, B.F., and Honn, K.V. (1984). Cysteine proteinases and metastasis. Cancer Metast. Rev. 3, 249-263.
91. Sloane, B.F., Rozhin, J., Hatfield, J.S., Crissman, J.D., and Honn, K.V. (1987). Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp. Cell Biol. 55, 209-224.
92. Sloane, B.F., Sameni, M., Cao, L., Berquin, I., Rozhin, J., Ziegler, G., Moin, K., and Day, N. (1994). Alterations in processing and trafficking of cathepsin B during malignant progression. In: Biological Functions of Proteases and Inhibitors, N. Katunuma, K. Suzuki, J. Travis and H. Fritz, eds. (Tokyo: Japan Scientific Societies Press), pp. 131-147.
93. Sokoloff, L., Malemud, C.J., Srivastava, V.M.L., and Morgan, W.D. (1973). In vitro culture of articular chondrocytes. Fed. Proc. 32, 1499-1502.
94. Spitznagel, J.K., and Shafer, W.M. (1985). Neutrophil killing of bacteria by oxygen-independent mechanisms: a historical summary. Rev. Infect. Dis. 7, 398-403.
95. Stadler, J., Stefanovic-Racic, M., Billlar, T.R., Curran, R.D., McIntyre, L.A., Georgescu, H.I., Simmons, R.L., and Evans, C.H. (1991). Articular chondrocytes synthesize nitric oxide in e to cytokines and lipopolysaccharide. J. Immunol. 147, 3915-3920.
96. Stetler-Stevenson, W.G., Liotta, L.A., and Kleiner, D.E., Jr. (1993) Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J, 7, 1434-1441.
97. Stone, P.J., Lucey, E.C., and Snider, G.L. (1990). Induction and exacerbation of emphysema in hamsters with human neutrophil elastase inactivated reversibly by a peptide boronic acid. Amer. Rev. Respir. Dis. 141, 47-52.
98. Storch, M., and Lassmannn, H. (1997). Pathology and pathogenesis of demyellnating diseases. Curr. Opin. Neurol. 10, 186-192.
99. Szedlacsek, S.E., and Duggleby, R.G. (1995). Kinetics of slow and tight-binding inhibitors. Meth. Enzymol. 249, 144-180.
100. Travis, J., and Fritz, H. (1991). Potential problems in deigning eiastase inhibitors for therapy. Amer. J.Respir. Dis. 143, 1412-1415.
101. Tyler, J.A. (1985). Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules. Biochem. J. 227, 869-878.
102. Tyler, J.A., and Benton, H.P. (1988). Synthesis of type II collagen is decreased in cartilage cultured with interleukln 1 while the rate of intracellular degradation remains unchanged. Collagen Related Res. 8, 393-405.
103. von der Mark, K., Kirsch, T., Nerlich, A., Kuss, A., Weseloh, G., Glückert, K., and Stöss, H. (1992). Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondroeyte hypertrophy. Arthritis Rheum. 35, 806-811.
104. Weinbaum, G., and Damiano, V.V. (1987). Protease inhibitor ther-apy in emphysema: a promising theory with problems. Trends Pharmacol. Sci. 8, 6-7.
105. Weiss, C. (1973). Ultrastructural characteristics of osteoarthritis. Fed. Proc. 32, 1459-1466.
106. Weiss, C., and Mirow, S. (1972). An ultrastructural study of osteoarthritic changes in the articular cartilage of human knees. J. Bone Joint Surg.-Amer. Vol. 54-A, 954-972.
107. Welgus, H.G., Jeffrey, J.J., Stricklin, G.R, Roswit, W.T., and Elsen, A.Z. (1980). Characteristics of the action of human skin fibroblast collagenase on fibrillar collagen. J. Biol. Chem. 255, 6806-6813.
108. Woodhouse, E.G., Chuaqui, R.F., and Liotta, L.A. (1997). General mechanisms of metastasis. Cancer 80, 1529-1537.
109. Yaron, I., Meyer, F.A., Dayer, J.M., Bleiberg, I., and Yaron, M. (1989). Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures. Arthritis Rheum. 32, 173-180.